These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3915413)

  • 21. The role of natural coagulation inhibitors in hemostasis.
    Brandt JT
    Clin Lab Med; 1984 Jun; 4(2):245-84. PubMed ID: 6094091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Alteration in coagulation and fibrinolysis after burn injury and significance of anticoagulation therapy using heparin and antithrombin III concentrate].
    Ono I
    Hokkaido Igaku Zasshi; 1987 Jan; 62(1):108-21. PubMed ID: 3817736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antithrombin-III activity in ischaemic heart disease.
    Sunder S; Kapil R; Dube B; Vaish SK
    Indian Heart J; 1984; 36(1):46-9. PubMed ID: 6423518
    [No Abstract]   [Full Text] [Related]  

  • 24. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood coagulation factors and glycosaminoglycans].
    Sakuragawa N; Takahashi K; Sato S; Niwa M; Yamagishi R; Kazama Y
    Rinsho Byori; 1987 Sep; Spec No 73():134-41. PubMed ID: 3437528
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemistry of heparin and low molecular weight heparin.
    Nielsen JI; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular characterization of the antithrombin III tours deficiency.
    Duchange N; Chasse JF; Cohen GN; Zakin MM
    Thromb Res; 1987 Jan; 45(1):115-21. PubMed ID: 3563974
    [No Abstract]   [Full Text] [Related]  

  • 28. Antithrombin III regulates complement activity in vitro.
    Weiler JM; Linhardt RJ
    J Immunol; 1991 Jun; 146(11):3889-94. PubMed ID: 2033259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antithrombin III and its role in clinical pathology].
    Andreenko GV; Poliantseva LR; Podorol'skaia LV
    Ter Arkh; 1980; 52(2):141-5. PubMed ID: 6445606
    [No Abstract]   [Full Text] [Related]  

  • 30. [The role of antithrombin III in disorders of blood coagulation].
    Król-Grela H; Piastucka B; Skotnicki AB
    Przegl Lek; 1988; 45(6):516-20. PubMed ID: 3075308
    [No Abstract]   [Full Text] [Related]  

  • 31. Antithrombin III, a serpin family protease inhibitor, is a major heparin binding protein in porcine aqueous humor.
    Rao PV; Allingham RR; Herndon LW; Epstein DL
    Biochem Biophys Res Commun; 2000 May; 272(1):1-5. PubMed ID: 10872794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antithrombin III and heparin].
    Zhu KC
    Zhonghua Fu Chan Ke Za Zhi; 1988 May; 23(3):177-9. PubMed ID: 3058418
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antithrombin III. Structure, pathophysiology, determination and therapeutic importance].
    Hrkal Z; Vorlová Z
    Cas Lek Cesk; 1992 Dec; 131(24-25):749-53. PubMed ID: 1288878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antithrombin III and heparin cofactor II].
    Kondo S; Niwa M
    Rinsho Byori; 1985 Feb; Spec No 61():106-13. PubMed ID: 3839027
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of antithrombin III as a regulator of in vivo coagulation.
    Bauer KA; Rosenberg RD
    Semin Hematol; 1991 Jan; 28(1):10-8. PubMed ID: 2017686
    [No Abstract]   [Full Text] [Related]  

  • 36. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antithrombin III-level in plasma preparations and coagulation active plasma fractions].
    Tausendfreund K; Uteg KH; Günther E
    Pharmazie; 1986 Sep; 41(9):662-3. PubMed ID: 3797460
    [No Abstract]   [Full Text] [Related]  

  • 38. [Regulation of blood coagulation by heparin and related proteins].
    Takahashi K; Niwa M; Yamagishi R; Sakuragawa N
    Rinsho Ketsueki; 1987 Jul; 28(7):1094-101. PubMed ID: 3694818
    [No Abstract]   [Full Text] [Related]  

  • 39. Laboratory evaluation of antithrombin III: a critical overview of currently available methods for antithrombin III measurements.
    Fareed J; Messmore HL; Walenga JM; Bermes EW; Bick RL
    Semin Thromb Hemost; 1982 Oct; 8(4):288-301. PubMed ID: 6817417
    [No Abstract]   [Full Text] [Related]  

  • 40. On the mechanism of coagulation inhibition on surfaces with end point immobilized heparin.
    Elgue G; Blombäck M; Olsson P; Riesenfeld J
    Thromb Haemost; 1993 Aug; 70(2):289-93. PubMed ID: 8236137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.